Rilpivirine Pharmacokinetics Without and With Darunavir/ritonavir once daily in Adolescents and Young Adults

BACKGROUND: Rilpivirine (RPV), a recently developed, once daily HIV non-nucleoside reverse transcriptase inhibitor (NNRTI), is not currently approved for pediatric patients, but is sometimes prescribed for adolescents with multiple treatment failures, for regimen simplification or to minimize toxici...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pediatr Infect Dis J
Autors principals: Foca, Marc, Yogev, Ram, Wiznia, Andrew, Hazra, Rohan, Jean-Philippe, Patrick, Graham, Bobbie, Britto, Paula, Carey, Vincent J., King, Jennifer, Acosta, Edward P., Cressey, Tim R.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5245132/
https://ncbi.nlm.nih.gov/pubmed/27187753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0000000000001214
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars